Skip to content

Degasil® Simeticonă 280 mg

by WALMARK, a.s. EUDAMED

Active European Union

Regulatory status

as of 27 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number2026-MDR/QS-011/B Date27 Aug 2026IssuedStatusActive expires 30 Jan 2031

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/MDR Active

Certificates

2 certificates · EUDAMED

EUDAMED certificates (2)
  • 2026-MDR/QS-011/B Amended

    Quality management system EU MDR

    Notified body
    3EC International a.s. 2265
    Issued
    27 Aug 2026
    Expires
    30 Jan 2031
    Reason
    Other
  • 2026-MDR/TD-011/B Amended

    Technical documentation EU MDR

    Notified body
    3EC International a.s. 2265
    Issued
    27 Aug 2026
    Expires
    30 Jan 2031
    Reason
    Other

Specification

EUDAMED

Device Name
Degasin 280 mg
Primary DI / UDI-DI
08596024030014
Basic UDI-DI
8596024DEGASIN280MG2K
EMDN Code
G99 Gastrointestinal devices - other
Device Class
Class III
Market of Registration
Romania

Manufacturer details

EUDAMED SRN
CZ-MF-000007035

Other devices from WALMARK, a.s.

See all devices from WALMARK, a.s. →

Properties

  • Animal Tissues

Other properties (12)

  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No